메뉴 건너뛰기
Neurology
Volumn 48, Issue 3, 1997, Pages 567-568
The therapeutic dilemma of inclusion body myositis
Author keywords

[No Author keywords available]
Indexed keywords

IMMUNOGLOBULIN;
EID: 0031093951     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.48.3.567     Document Type: Editorial
Times cited : (25)
References (13)
  • 1
    • 0029957253 scopus 로고    scopus 로고
    • Inclusion body myositis: clinical and pathologic boundaries.
    • Amato AA, Gronseth GS, Jackson CE, et al. Inclusion body myositis: clinical and pathologic boundaries. Ann Neurol 1996;40:581-586.
    • (1996) Ann Neurol , vol.40 , pp. 581-586
    • Amato, A.A.1    Gronseth, G.S.2    Jackson, C.E.3
  • 2
    • 0028787389 scopus 로고
    • Inclusion body myositis and myopathies.
    • Griggs RC, Askanas V, DeMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
    • (1995) Ann Neurol , vol.38 , pp. 705-713
    • Griggs, R.C.1    Askanas, V.2    DeMauro, S.3
  • 3
    • 0026429550 scopus 로고
    • Polymyositis, dermatomyositis, and inclusion body myositis.
    • Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 1991;325:1487-1498.
    • (1991) N Engl J Med , vol.325 , pp. 1487-1498
    • Dalakas, M.C.1
  • 4
    • 0026327717 scopus 로고
    • Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments.
    • Mendell JR, Sahenk Z, Gales T, Paul L. Amyloid filaments in inclusion body myositis: novel findings provide insight into nature of filaments. Arch Neurol 1991;48:1229-1234.
    • (1991) Arch Neurol , vol.48 , pp. 1229-1234
    • Mendell, J.R.1    Sahenk, Z.2    Gales, T.3    Paul, L.4
  • 5
    • 9044250101 scopus 로고    scopus 로고
    • Sporadic inclusion body myositis: counts of different types of abnormal fibers.
    • Pruitt JN II, Showalter CJ, Engel AG. Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 1996;39:139-143.
    • (1996) Ann Neurol , vol.39 , pp. 139-143
    • Pruitt, J.N.1    Showalter, C.J.2    Engel, A.G.3
  • 6
    • 0029086623 scopus 로고
    • Inclusion body myositis: explanation for poor response to immunosuppressive therapy.
    • Barohn RJ, Amato AA, Sahenk Z, Kissel JT, Mendell JR. Inclusion body myositis: explanation for poor response to immunosuppressive therapy. Neurology 1995;45:1302-1304.
    • (1995) Neurology , vol.45 , pp. 1302-1304
    • Barohn, R.J.1    Amato, A.A.2    Sahenk, Z.3    Kissel, J.T.4    Mendell, J.R.5
  • 7
    • 0026516454 scopus 로고
    • A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre Syndrome.
    • van der Meche FGA, Schmitz PIM, Butch Guillain-Barre Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre Syndrome. N Engl J Med 1992;326:1123-1129.
    • (1992) N Engl J Med , vol.326 , pp. 1123-1129
    • van der Meche, F.1    Schmitz, P.2    Butch Guillain-Barre Study, G.3
  • 8
    • 0027729939 scopus 로고
    • A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
    • Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.
    • (1993) N Engl J Med , vol.329 , pp. 1993-2000
    • Dalakas, M.C.1    Illa, I.2    Dambrosia, J.M.3
  • 9
    • 0027159872 scopus 로고
    • Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin.
    • Soueidan SA, Dalakas MC. Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin. Neurology 1993;43:876-879.
    • (1993) Neurology , vol.43 , pp. 876-879
    • Soueidan, S.A.1    Dalakas, M.C.2
  • 11
    • 0030947027 scopus 로고    scopus 로고
    • Treatment of inclusion body myositis with IVIG: a double-blind, placebo-control study.
    • Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion body myositis with IVIG: a double-blind, placebo-control study. Neurology 1997;48:712-716.
    • (1997) Neurology , vol.48 , pp. 712-716
    • Dalakas, M.C.1    Sonies, B.2    Dambrosia, J.3    Sekul, E.4    Cupler, E.5    Sivakumar, K.6
  • 12
    • 0024332294 scopus 로고
    • Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
    • Mendell JR, Moxley RT, Griggs RC, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320:1592-1597.
    • (1989) N Engl J Med , vol.320 , pp. 1592-1597
    • Mendell, J.R.1    Moxley, R.T.2    Griggs, R.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.